These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15879497)

  • 21. Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables.
    Johannsdottir HK; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Johannsson OT; Heikkilä P; Egilsson V; Olsson H; Borg A; Nevanlinna H; Barkardottir RB
    Anticancer Res; 2004; 24(5A):2681-7. PubMed ID: 15521105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing.
    Farshid G; Balleine RL; Cummings M; Waring P;
    Am J Surg Pathol; 2006 Nov; 30(11):1357-66. PubMed ID: 17063074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular pathology of hereditary breast cancer.
    Palacios J; Robles-Frías MJ; Castilla MA; López-García MA; Benítez J
    Pathobiology; 2008; 75(2):85-94. PubMed ID: 18544963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRCA1 and BRCA2 mutations in a South American population.
    Jara L; Ampuero S; Santibáñez E; Seccia L; Rodríguez J; Bustamante M; Martínez V; Catenaccio A; Lay-Son G; Blanco R; Reyes JM
    Cancer Genet Cytogenet; 2006 Apr; 166(1):36-45. PubMed ID: 16616110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
    Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
    Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
    Li WF; Hu Z; Rao NY; Song CG; Zhang B; Cao MZ; Su FX; Wang YS; He PQ; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Liu XY; Zhou J; Wang L; Zhao L; Liu YB; Yuan WT; Yang L; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2008 Jul; 110(1):99-109. PubMed ID: 17851763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
    Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
    Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer.
    Tilanus-Linthorst MM; Alves C; Seynaeve C; Menke-Pluymers MB; Eggermont AM; Brekelmans CT
    Br J Surg; 2006 Aug; 93(8):961-8. PubMed ID: 16758466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.
    Fatouros M; Baltoyiannis G; Roukos DH
    Ann Surg Oncol; 2008 Jan; 15(1):21-33. PubMed ID: 17940826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent.
    Oros KK; Ghadirian P; Maugard CM; Perret C; Paredes Y; Mes-Masson AM; Foulkes WD; Provencher D; Tonin PN
    Clin Genet; 2006 Oct; 70(4):320-9. PubMed ID: 16965326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The estrogen receptor alpha C975G variant in familial and sporadic breast cancer: a case-control study.
    Skoglund J; Margolin S; Zhou XL; Maguire P; Werelius B; Lindblom A
    Anticancer Res; 2006; 26(4B):3077-81. PubMed ID: 16886637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TP53 mutations in familial breast cancer: functional aspects.
    Gasco M; Yulug IG; Crook T
    Hum Mutat; 2003 Mar; 21(3):301-6. PubMed ID: 12619116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer.
    Zhou XL; Werelius B; Lindblom A
    Breast Cancer Res; 2004; 6(3):R187-90. PubMed ID: 15084242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterozygote BRCA1 status and skewed chromosome X inactivation.
    Helbling-Leclere A; Lenoir GM; Feunteun J
    Fam Cancer; 2007; 6(1):153-7. PubMed ID: 16944269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of nuclear BRCA1 localization in breast carcinoma is age dependent.
    Bogdani M; Teugels E; De Grève J; Bourgain C; Neyns B; Pipeleers-Marichal M
    Virchows Arch; 2002 Mar; 440(3):274-9. PubMed ID: 11889597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of new point mutations of BRCA1 and BRCA2 in breast cancer patients.
    Bensam M; Hafez E; Awad D; El-Saadani M; Balbaa M
    Biochem Genet; 2014 Feb; 52(1-2):15-28. PubMed ID: 23877192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma.
    Beger C; Ramadani M; Meyer S; Leder G; Krüger M; Welte K; Gansauge F; Beger HG
    Clin Cancer Res; 2004 Jun; 10(11):3780-7. PubMed ID: 15173085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis.
    Uz E; Mustafa C; Topaloglu R; Bilginer Y; Dursun A; Kasapcopur O; Ozen S; Bakkaloglu A; Ozcelik T
    Arthritis Rheum; 2009 Nov; 60(11):3410-2. PubMed ID: 19877028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
    Martin ST; Matsubayashi H; Rogers CD; Philips J; Couch FJ; Brune K; Yeo CJ; Kern SE; Hruban RH; Goggins M
    Oncogene; 2005 May; 24(22):3652-6. PubMed ID: 15806175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.